Brickell Biotech, Inc. BBI
2.35 +2.35
Day range unavailable
52-week range unavailable
News
globenewswire.com Boundless Bio Presents Preclinical Breast Cancer Data from its Oral Kinesin Degrader Program at 2026 AACR Annual Meeting Findings support the ongoing Phase 1 clinical development of BBI-940, an oral, selective kinesin degrader, as a potential first-in-class therapy for select advanced or metastatic breast cancers…
seekingalpha.com Boundless Bio: An Underestimated Biotech With A First-In-Class EcDNA Targeted Kinesin Degrader Boundless Bio offers a highly asymmetric risk/reward profile, trading at a $25M valuation with $107.6M in cash and a runway into 2H 2028. BBI-940, BOLD's first direct ecDNA-targeting asset, is…
globenewswire.com PRESS RELEASE: NACON announces the temporary suspension of trading in its shares on Euronext Paris Press Release Lesquin, 20 February 2026, 7.30 NACON announces the temporary suspension of trading in its shares on Euronext Paris Lesquin, 20 February 2026, Nacon (the “Company”) announces that it…
globenewswire.com Boundless Bio Advances Novel Kinesin Degrader Program BBI-940 and Extends Cash Runway BBI-940 IND accepted; initiation of first-in-human clinical trial on track for the first half of 2026 Portfolio prioritization, including discontinuation of POTENTIATE trial, extends operating runway…
globenewswire.com Boundless Bio Announces Portfolio Prioritization and Runway Extension Portfolio prioritization focuses on novel-novel combination therapy of BBI-355 and BBI-825 and new development candidate, BBI-940, for novel kinesin program
globenewswire.com Boundless Bio Announces Pipeline and Leadership Updates Company elects not to advance BBI-825 into Part 2 portion of STARMAP clinical trial Third ecDTx program advancing, with plans for development candidate nomination by mid-2025 Operating runway…
globenewswire.com Boundless Bio Reports Third Quarter 2024 Financial Results and Business Highlights Enrollment progressing in BBI-355 POTENTIATE and BBI-825 STARMAP clinical trials, with initial proof-of-concept data expected in the second half of 2025
globenewswire.com Fresh Tracks Therapeutics Announces Second Adjournment of Special Meeting of Stockholders Meeting adjourned to December 15, 2023 at 10 a.m. MT
globenewswire.com Fresh Tracks Therapeutics Announces Adjournment of Special Meeting of Stockholders Meeting adjourned to November 30, 2023 at 10 a.m. MT Fresh Tracks encourages all stockholders of record on October 17, 2023 who have not yet voted to do so by 11:59 p.m.
globenewswire.com Fresh Tracks Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update Cash and cash equivalents of approximately $11.5 million as of October 31, 2023 Special meeting of stockholders on November 16 seeking stockholder approval of the Dissolution and Plan of Dissolution…
globenewswire.com Fresh Tracks Therapeutics Announces Board Approval of Plan of Liquidation and Dissolution Company intends to make cash distributions currently estimated to be between $5 million and $7 million, or $0.84 to $1.17 per share, to shareholders following shareholder approval and the filing of…
globenewswire.com Fresh Tracks Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update Strengthened current cash position to approximately $15 million as of July 31, 2023 as a result of sale of future rights to event-based milestone and earnout payments on net sales of sofpironium…
globenewswire.com Fresh Tracks Announces $8.25 Million Buyout of Its Right to Receive Future Sofpironium Bromide Payments from Botanix Strengthens cash position as Company continues to evaluate strategic options to maximize shareholder value Strengthens cash position as Company continues to evaluate strategic options to maximize…
globenewswire.com Fresh Tracks Therapeutics to Report Third Quarter 2022 Financial Results and Provide a Corporate Update on November 10, 2022 BOULDER, Colo., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Fresh Tracks Therapeutics, Inc. (“Fresh Tracks Therapeutics” or the “Company”) (Nasdaq: FRTX), a clinical-stage pharmaceutical company aiming to…
seekingalpha.com Brickell Biotech, Inc. (BBI) CEO Robert Brown on Q2 2022 Results - Earnings Call Transcript Brickell Biotech, Inc. (NASDAQ:BBI ) Q2 2022 Earnings Conference Call August 11, 2022 4:30 PM ET Company Participants Garth Russell - IR, LifeSci Advisors Robert Brown - Chief Executive Officer…
benzinga.com Earnings Scheduled For August 11, 2022 Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million.
benzinga.com This Biotechnology Stock Jumped Over 360%; Here Are 106 Biggest Movers From Yesterday Gainers Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) shares surged 360.5% to settle at $19.80 on Wednesday on above-average volume.
pulse2.com Brickell Biotech (BBI) Stock: 1-For-45 Reverse Split Announced Brickell Biotech, Inc. (Nasdaq: BBI) announced a 1-for-45 reverse split. These are the details.
benzinga.com This Healthcare Stock Surges Around 115%, Here's 74 Biggest Movers From Yesterday Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) shares surged 114.3% to close at $0.2550 on Wednesday after the company announced it has terminated its previously announced at-the-market offering.
investorplace.com Brickell Biotech (BBI) Stock Gains 50% Ahead of Meeting to Prevent Delisting Delistings are commonplace in this bear market, however investors in Brickell Biotech and BBI stock are cheering some news today. The post Brickell Biotech (BBI) Stock Gains 50% Ahead of Meeting to…
pennystocks.com 3 Penny Stocks To Watch After GDP Report Penny stocks to buy or avoid right now? You decide after seeing the latest updates from 3 companies.
pennystocks.com Top Penny Stocks To Buy? 4 Biotech Stocks To Watch Now Biotech penny stocks to watch in June. The post Top Penny Stocks To Buy?
benzinga.com Stocks That Hit 52-Week Lows On Tuesday On Tuesday, 540 companies set new 52-week lows.
benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 216 stocks hit new 52-week lows.- benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday, 153 companies set new 52-week lows.
zacks.com Brickell (BBI) Reports Q1 Loss, Lags Revenue Estimates Brickell (BBI) delivered earnings and revenue surprises of -33.33% and 52.33%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?- benzinga.com Earnings Scheduled For May 12, 2022 Companies Reporting Before The Bell • Chicago Atlantic Real (NASDAQ:REFI) is projected to report earnings for its first quarter.
- benzinga.com 81 Biggest Movers From Yesterday Gainers Rail Vision Ltd. (NASDAQ: RVSN) shares climbed 62.4% to close at $2.16 on Wednesday after gaining around 5% on Tuesday.
- benzinga.com 50 Stocks Moving In Wednesday's Mid-Day Session Gainers Rail Vision Ltd. (NASDAQ: RVSN) shares jumped 51.7% to $2.0180 after gaining around 5% on Tuesday.
- benzinga.com 68 Biggest Movers From Yesterday Gainers Casa Systems, Inc. (NASDAQ: CASA) shares surged 82.5% to close at $7.10 on Monday after the company announced a multi-year contract with Verizon to provide 5G core network functions.
- benzinga.com Earnings Scheduled For March 15, 2022 Companies Reporting Before The Bell • IDEAYA Biosciences (NASDAQ:IDYA) is likely to report quarterly loss at $0.31 per share on revenue of $8.98 million.
- benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- benzinga.com 28 Stocks Moving in Wednesday's Pre-Market Session Gainers Guardion Health Sciences, Inc. (NASDAQ: GHSI) rose 46.4% to $0.4098 in pre-market trading after jumping around 48% on Tuesday. Guardion Health Sciences recently reported closing of $11…
benzinga.com 52 Biggest Movers From Yesterday Gainers Zogenix, Inc. (NASDAQ: ZGNX) shares surged 65.7% to close at $25.92 on Wednesday after the company announced it will be acquired by UCB for approximately $1.9 billion.- benzinga.com 35 Stocks Moving In Wednesday's Mid-Day Session Gainers Zogenix, Inc. (NASDAQ: ZGNX) shares jumped 67.1% to $26.15 after the company announced it will be acquired by UCB for approximately $1.9 billion.
benzinga.com 65 Biggest Movers From Yesterday Gainers Brickell Biotech, Inc. (NASDAQ: BBI) shares jumped 58.6% to settle at $0.33 on Tuesday after HC Wainwright & Co initiated coverage on the stock with a Buy rating and $2 price target.- benzinga.com Stocks That Hit 52-Week Lows On Friday During Friday's session, 445 companies made new 52-week lows.
- benzinga.com Earnings Scheduled For November 9, 2021 Companies Reporting Before The Bell • Imara (NASDAQ:IMRA) is projected to report earnings for its third quarter. • KT (NYSE:KT) is projected to report earnings for its third quarter.
- benzinga.com Earnings Scheduled For August 12, 2021 Companies Reporting Before The Bell • Anavex Life Sciences (NASDAQ:AVXL) is estimated to report earnings for its third quarter.
- benzinga.com Earnings Scheduled For May 13, 2021 Companies Reporting Before The Bell • CASI Pharmaceuticals (NASDAQ:CASI) is estimated to report quarterly loss at $0.06 per share on revenue of $5.05 million.
- benzinga.com Earnings Scheduled For March 9, 2021 Companies Reporting Before The Bell • Barnes & Noble Education (NYSE:BNED) is expected to report quarterly loss at $0.38 per share on revenue of $397.48 million.
- benzinga.com Earnings Scheduled For November 12, 2020 Companies Reporting Before The Bell • Redhill Biopharma (NASDAQ:RDHL) is projected to report quarterly loss at $0.16 per share on revenue of $25.37 million. • Alithya Group (NASDAQ:ALYA) is expected…
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday During Wednesday's morning trading, 129 companies set new 52-week lows. Areas of Interest: The largest company in terms of market cap to set a new 52-week low was Wells Fargo (NYSE: WFC).
- benzinga.com Earnings Scheduled For August 12, 2020 Companies Reporting Before The Bell • Brinker International Inc. (NYSE:EAT) is expected to report quarterly loss at $1.43 per share on revenue of $571.05 million.
- benzinga.com 62 Biggest Movers From Yesterday Gainers
benzinga.com 65 Biggest Movers From Yesterday Gainers Urban One, Inc. (NASDAQ: UONE) shares jumped 255.4% to close at $6.54 on Monday after surging around 22% on Friday.
benzinga.com Stocks That Hit 52-Week Lows On Thursday - benzinga.com 95 Biggest Movers From Yesterday
- benzinga.com 50 Stocks Moving in Thursday's Pre-Market Session
- benzinga.com Stocks That Hit 52-Week Lows On Thursday